POLLUTION AND THE RISE OF AMR
A Changing Markets Foundation report reveals the presence of drug-resistant bacteria at pharmaceutical manufacturing sites in India. It casts light on the supply chain that links the factories investigated to companies, public health services, and hospitals in the United States and Europe.
It’s vital that the healthcare key actors only purchase antibiotics from manufacturers that do not pollute the environment and introduce more transparency in the supply chain. In the following infographic, you can learn more about the sources of AMR (antimicrobial resistance).
Leave a Reply
Want to join the discussion?Feel free to contribute!